Back to Screener

Arcadia Biosciences, Inc. (RKDA)

Price$1.07
Value ScoreA
Growth ScoreD
Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-78.13%
Price vs S&P 500 (4W)0.01%
VGM Score44.78
Market Capitalization$2.20M

All Metrics

Book Value / Share (Quarterly)$1.40
P/TBV (Annual)0.66x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-21.28%
Cash Flow / Share (Quarterly)$-2.07
Price vs S&P 500 (YTD)-54.12%
Gross Margin (TTM)34.49%
Net Profit Margin (TTM)-195.94%
EPS (TTM)$-5.72
10-Day Avg Trading Volume0.22M
EPS Excl Extra (TTM)$-5.72
Revenue Growth (5Y)-9.56%
EPS (Annual)$-1.71
ROI (Annual)-56.50%
Gross Margin (Annual)36.23%
Net Profit Margin (5Y Avg)-164.12%
Cash / Share (Quarterly)$1.81
Revenue Growth QoQ (YoY)-8.33%
ROA (Last FY)-35.73%
Revenue Growth TTM (YoY)-9.53%
EBITD / Share (TTM)$-2.44
ROE (5Y Avg)-79.75%
Operating Margin (TTM)-80.01%
Cash Flow / Share (Annual)$-3.45
P/B Ratio0.76x
P/B Ratio (Quarterly)0.98x
Net Income / Employee (Annual)$-292,400
EV / Revenue (TTM)0.26x
Net Interest Coverage (TTM)-5.23x
ROA (TTM)-132.05%
EPS Incl Extra (Annual)$-1.71
Current Ratio (Annual)3.09x
Quick Ratio (Quarterly)3.04x
3-Month Avg Trading Volume0.73M
52-Week Price Return-77.66%
Revenue / Employee (TTM)$594,800
Tangible BV / Share (Quarterly)$1.38
P/S Ratio (Annual)0.45x
Asset Turnover (Annual)0.74x
52-Week High$6.71
Operating Margin (5Y Avg)-186.92%
EPS Excl Extra (Annual)$-1.71
CapEx CAGR (5Y)-59.56%
Tangible BV CAGR (5Y)-31.58%
26-Week Price Return-70.20%
Quick Ratio (Annual)2.42x
13-Week Price Return-40.56%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)3.79x
Enterprise Value$1.25M
Revenue / Share Growth (5Y)-35.63%
Asset Turnover (TTM)0.67x
Book Value / Share Growth (5Y)-48.29%
Revenue / Employee (Annual)$607,200
Inventory Turnover (Annual)2.93x
Pretax Margin (Annual)-47.98%
Cash / Share (Annual)$3.32
3-Month Return Std Dev75.42%
Gross Margin (5Y Avg)36.58%
Net Income / Employee (TTM)$-1,165,400
ROE (Last FY)-56.50%
Net Interest Coverage (Annual)-2.98x
EPS Basic Excl Extra (Annual)$-1.71
Receivables Turnover (TTM)4.66x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-5.72
Receivables Turnover (Annual)6.07x
ROI (TTM)-219.35%
P/S Ratio (TTM)0.46x
Pretax Margin (5Y Avg)-125.55%
Revenue / Share (Annual)$3.55
Tangible BV / Share (Annual)$2.99
Price vs S&P 500 (52W)-102.03%
Year-to-Date Return-45.96%
5-Day Price Return16.76%
EPS Normalized (Annual)$-1.71
ROA (5Y Avg)-49.06%
Net Profit Margin (Annual)-48.15%
Month-to-Date Return10.89%
Cash Flow / Share (TTM)$-13.95
EBITD / Share (Annual)$-1.80
Operating Margin (Annual)-51.46%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-79.75%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-5.72
P/TBV (Quarterly)1.00x
P/B Ratio (Annual)0.66x
Inventory Turnover (TTM)2.93x
Pretax Margin (TTM)-195.78%
Book Value / Share (Annual)$3.02
Price vs S&P 500 (13W)-48.81%
Beta0.49x
Revenue / Share (TTM)$2.28
ROE (TTM)-219.35%
52-Week Low$0.80
vGradeA
gGradeD
mGradeF
vgmGradeC
Show chart for

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14

About

Arcadia Biosciences creates high-value crop improvements in wheat, soy, and hemp designed to enhance farm economics and ingredient value. The company commercializes these innovations through consumer brands including GoodWheat high-fiber pasta and Zola coconut water, as well as health, wellness, and industrial applications.